Antidepressants vs Microdosing

If you’ve been on antidepressants for a while, or if you’ve tried several without finding one that actually worked, you’ve probably started looking for alternatives. Microdosing psychedelics is one option that keeps coming up. This article compares the two honestly: what each does, what the evidence shows, and where they differ.

No treatment is a cure-all, and what works for one person may not work for you. The goal here is to give you clear information so you can have a better conversation with someone who knows your history.

If you’re specifically researching psilocybin for depression, we’ve written a detailed evidence review covering the clinical trials, what’s available in Europe, and what the therapy actually involves.

What are antidepressants?

Antidepressants are a group of medications used to treat depression, anxiety, PTSD, and several other mental health conditions. Almost one in ten Americans currently take one, and for many they bring meaningful relief. For others, the effect is partial or missing altogether: more than a third of people with depression don’t fully respond to the best available antidepressants.

Since the 1950s, antidepressants have been prescribed based on the idea that depression is linked to low levels of neurotransmitters (brain chemicals that influence mood), notably serotonin, norepinephrine, and dopamine. Most modern antidepressants work by raising the levels of these chemicals in the brain, which can help regulate mood and reduce symptoms over time.

A widely discussed umbrella review by Moncrieff et al. (2022) concluded that there is “no convincing evidence” that low serotonin directly causes depression. The review sparked significant debate, with multiple peer-reviewed rebuttals arguing it overstated its case. The simple “chemical imbalance” story has been considered outdated for decades, though antidepressants continue to help many people through mechanisms that are still not fully understood.

It’s also worth noting that some of the earliest antidepressants were discovered by accident: a tuberculosis drug developed from repurposed post-war chemicals unexpectedly lifted patients’ moods. More recently, Spravato (a nasal-spray form of ketamine) was approved in 2019 for depression that hasn’t responded to standard medications. In other words, the line between “antidepressant” and “psychedelic” has never been as clean as it looks.

How are psychedelics different?

Psychedelics such as psilocybin and LSD act mainly on certain receptors in the brain linked to mood and perception (called serotonin 5-HT2A receptors). They don’t broadly raise serotonin levels the way antidepressants do. Instead, by activating this specific receptor, they change how brain cells communicate with each other. Researchers believe this is what produces their unique effects, including shifts in perception, stronger emotions, and the kind of deeply meaningful experiences people often describe after a session.

One big difference between psychedelics and antidepressants is how quickly they work. Psychedelics can produce noticeable improvements in mood within hours or days. Antidepressants typically take several weeks before you feel a real shift.

Another difference is that the effects of psychedelics can last a long time after a single dose. Some studies have reported sustained improvements in mood for weeks or months after one session. Antidepressants, on the other hand, need to be taken regularly to keep working.

Psychedelics can also feel much more intense than taking a pill. The experience itself is the treatment, which is part of why careful preparation, a trusted setting, and integration afterwards matter so much. Used carelessly, they can be overwhelming. Used with proper support, many people describe them as among the most meaningful experiences of their lives.

Both treatments have benefits and limits. We’d recommend talking this through with someone who knows your personal history and can help you weigh the options.

What is microdosing?

Microdosing is the practice of taking very small amounts of a psychedelic substance, such as psilocybin mushrooms or LSD, on a regular schedule. A typical microdose is about one-tenth of a recreational dose or less. The idea is to get subtle, grounded effects on mood, focus, or outlook without ever “tripping.”

Most people who microdose follow a schedule like once every three days for several weeks, often with planned breaks. The goal is everyday functioning with a small lift, not an altered state.

Interest has grown in recent years around microdosing as a possible support for depression, anxiety, and PTSD. People who microdose often report improvements in creativity, focus, and overall wellbeing. The scientific evidence is still catching up with these reports.

Is microdosing safe?

This is an important question, and an honest answer has two sides.

On one hand, psilocybin mushrooms have been used by Indigenous communities for generations and are generally considered low in toxicity at modest doses. After decades of research being blocked by the War on Drugs that began in the late 1960s, studies into psychedelics have restarted in the past several years at major medical institutions, and early findings are encouraging.

On the other hand, we still don’t fully understand the long-term effects of repeated microdosing. Some people report increased anxiety, restlessness, or a sense of emotional instability, especially at higher microdoses or when taken too frequently. If you already live with depression or anxiety, these effects can hit harder, which is exactly why doing this with professional guidance matters.

There are also practical safety issues. If mushrooms are involved, identification matters: hundreds of species produce psilocybin, but lookalikes can be toxic, so the source has to be trustworthy. And because psychedelics are illegal in many places, doing this outside a supervised setting carries legal risks as well as health ones.

None of this is meant to scare you off. It’s meant to be realistic: the risks are real but generally manageable when you have the right support, the right source, and the right expectations.

Could psychedelics become safer if legalised?

Research into medical use is moving forward, though approval timelines remain uncertain. In August 2024, the FDA declined to approve MDMA-assisted therapy for PTSD, asking for additional clinical trials. In April 2026, a U.S. executive order directed the FDA to issue priority review vouchers for psychedelic treatments with Breakthrough Therapy designation, aiming to shorten approval timelines from years to weeks. Psilocybin research is further along in some jurisdictions, and the COMPASS Pathways psilocybin trial reported positive late-stage results in early 2026 for depression that hasn’t responded to standard medications.

Several public figures, clinicians, and policymakers believe that decriminalising psychedelics and regulating how they’re grown and produced would actually make them safer. In a number of places around the world, they are no longer treated as strictly illegal.

Supporters of decriminalisation expect better quality control and easier access, potentially including use without a prescription. Skeptics worry that unrestricted access could lead to more misuse and harm without proper supervision, particularly for people with mental health conditions where the experience could be destabilising. Both concerns are reasonable, and the policy answer likely sits somewhere in the middle: regulated, supervised, and accessible to the people who could benefit.

The benefits of psychedelics vs. antidepressants

Both options can help with depression, but they work very differently. Here’s what each tends to offer.

Benefits of psychedelics for depression

1. Faster onset. Psychedelics like psilocybin and ketamine can produce noticeable improvements in mood within hours or days. Traditional antidepressants usually take several weeks.
2. Long-lasting effects from short treatments. Some studies have reported sustained improvements for weeks or months after a single guided session.
3. A different kind of therapeutic effect. People often describe psychedelic sessions as genuinely meaningful experiences that shift how they see themselves, their relationships, or their situation. These shifts can be linked to lasting changes in mood and behaviour.

Benefits of antidepressants for depression

1. Widely available. Antidepressants can be prescribed by any doctor and obtained at most pharmacies. You don’t need to travel or find a specialised programme.
2. Evidence-based. Decades of clinical research support their use, and they are a first-line treatment for moderate to severe depression.
3. Predictable. Once you find one that works for you, the effect is relatively steady and doesn’t depend on the setting or context.

Microdosing psychedelics for severe depression

Microdosing psilocybin or LSD has become popular as a possible aid for severe depression (clinically called Major Depressive Disorder, or MDD). Scientific evidence specifically on microdosing for MDD is still limited, but some early results are interesting.

A small study published in the Journal of Affective Disorders found that microdosing LSD was associated with reduced symptoms of depression and anxiety in a group of self-selected participants. Another study in the Journal of Psychopharmacology found that microdosing psilocybin was associated with greater emotional stability, fewer depressive symptoms, and improved attention, again in self-selected participants.

These findings are encouraging but not conclusive. Self-selected participants can skew results, and placebo effects are harder to rule out than in formal trials. Microdosing shouldn’t be treated as a standalone cure. It works best alongside other support: talk therapy, behavioural tools, and people who know your situation.

Should you start with psilocybin or LSD for microdosing?

The short answer: probably neither, at least not on your own.

The practice of microdosing is not yet well understood, and there is limited scientific research on its safety, long-term effects, and how it compares across substances. Buying, possessing, or using psilocybin or LSD outside of a controlled therapeutic setting is illegal in most places and carries real risks, both legal and personal. If you’re serious about trying a psychedelic approach, the safest path is through a licensed therapist or an approved clinical programme.

Once you have proper guidance in place, the choice between psilocybin and LSD often comes down to legal access in your country and what your clinician recommends based on your history.

The future of microdosing

Attitudes toward psilocybin are shifting quickly. In therapeutic settings, psilocybin-containing substances like magic mushrooms are gradually moving toward wider acceptance and, in some places, legal use.

Microdosing is often described as offering meaningful benefits with less intense experiences than full doses, though the research is still catching up with these reports. Full doses of psychedelics can be very intense, and microdoses are far easier to integrate into everyday life.

It’s possible that psilocybin will eventually be available through regulated clinical channels, similar to other prescribed treatments, though this is likely years away. Until then, the most reliable route is through approved research programmes and licensed providers in jurisdictions where this work is legal.

Conclusion

Both psychedelics and antidepressants can help with depression, and both have real trade-offs.

Psychedelics, including microdosing, may offer a faster onset and unique therapeutic effects, but access is limited and evidence for microdosing specifically is still early. Antidepressants are widely available, well-studied, and predictable, but don’t work for everyone and can come with side effects.

What’s right for you depends on your history, what you’ve already tried, and what support you can put in place. This is a conversation worth having with a clinician you trust.

If you’re at a difficult point right now, you’re not alone. Reach out to someone you trust, or to a mental health crisis line in your country. Professional support is available, and asking for it is a strength, not a weakness.